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Developmental programing is gaining considerable leverage as a conceptual framework
for understanding individual variability in human behavioral and somatic health. The cur-
rent mini-review examines some of the key conceptual and methodological challenges
for developmental programing research focused on fetal sex steroid exposure and phys-
ical, behavioral, physiological, and health outcomes. Specifically, we consider the bases
for focusing on sex steroids, methods for assessing prenatal steroid hormone exposure,
confounding factors, and the most relevant postnatal outcomes. We conclude with a brief
consideration, based on current knowledge, of the applications of the existing findings for
further research and practice.
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The developmental origins of health and disease hypothesis and
the programing mechanisms that underlie it are a major focus
of current basic science and clinical health research. A common
theme is that stress (or in humans, anxiety) experienced by the
mother is transmitted to the fetus and the ensuing developmen-
tal changes may have long-lasting effects on offspring biology and
behavior. The hypothalamic–pituitary–adrenal (HPA) axis – and
particularly glucocorticoid exposure – has attracted attention as a
likely mediating mechanism (1–3). However, it may be worthwhile
to look beyond the HPA axis. In this mini-review, we consider the
role that sex steroids may play in prenatal programing and iden-
tify strategies for managing some of the methodological challenges
that have arisen.
PROGRAMING EFFECTS FROM PRENATAL STRESS/ANXIETY:
SEX STEROIDS
It is natural that HPA axis-mediated programing mechanisms
have attracted substantial research attention given the dominant
role of prenatal stress as a “risk phenotype” in the animal and,
more recently, human research. The mediating role of gluco-
corticoids in programing fetal physiology may extend beyond
prenatal psychosocial stress to also include exposure to other
types of stressors, such as nutritional deprivation. Moreover,
there are equally compelling reasons why an exclusive focus on a
glucocorticoid-mediated mechanism will be inadequate and con-
sideration of complementary mechanisms, notably sex steroid
hormones, could be informative. For example, the HPA and
hypothalamic–pituitary–gonadal (HPG) axes show considerable
overlap and interaction (4); just as stress may affect sex steroid
hormone production, so sex steroids may act on the stress response
system.
One way of evaluating the likely importance of sex steroids in
developmental programing is to examine sex differences in the
associations between prenatal stress and outcomes in offspring.
For instance, in animal models, male and female offsprings often
show different patterns of developmental programing (5). In some
cases, only one sex appears to be affected by prenatal stress (6), but
in other research, the sexes show opposite directions of effect. For
example, in a rat model, prenatal restraint stress was associated
with increased anxiety in males but decreased anxiety in females
compared to controls (7).
Whether or not there are sex differences in human studies
of the effects of prenatal stress/anxiety on child outcomes is far
from clear. Some examples have been reported for behavioral and
cognitive development (8, 9) and the evidence for cardiovascular
outcomes is strong (10). However, for several of the most widely
researched stress-related outcomes, such as behavioral and emo-
tional problems and HPA axis function, few, if any, robust and
consistent sex differences have been found (11, 12). This inconsis-
tency across human studies raises several critical issues. First, there
is no reason to expect that responses to prenatal stress will differ
by sex across all traits, so carefully selecting only those phenotypes
of most relevance is important. Second, it is plausible that focus-
ing on HPA axis-mediated mechanisms, to the exclusion of other
mediators, may have limited our ability to detect and understand
sex differences.
Two lines of study provide evidence of sex steroid involvement
in stress-related developmental programing. In animal models,
prenatal stress is associated with changes in anogenital distance
(AGD), a marker of prenatal androgen exposure; these associ-
ations have now been noted in humans (13–15). Critically, the
direction of effects differs by sex: prenatal stressed males show
demasculinization and females show masculinization of AGD.
Interestingly, in contrast to the literature on prenatal nutritional
stress, in which males tend to be more affected postnatally (16), the
effects of psychosocial stress on reproductive development appear
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to be stronger in females (13, 17). Although research on prena-
tal stress and reproductive health and development in humans is
limited, the fact that AGD appears to be stable over time and has
been linked to adult reproductive outcomes (18, 19) suggests the
potential importance of this line of research. A related line of work
suggests prenatal programing from sex steroids from testosterone
in amniotic fluid on autistic behaviors (20, 21) as well as tem-
perament and play behavior (9, 22) in childhood. These findings
point to the need for further clinical research on developmental
programing of sex steroids and their effects on human health and
development.
METHODOLOGICAL CHALLENGES FOR INVESTIGATING
PRENATAL PROGRAMING EFFECTS OF SEX STEROIDS IN
HUMAN STUDIES
There are several methodological challenges for future research on
the possible programing role of prenatal sex steroid exposure; we
consider several in this mini-review.
ASSESSING FETAL EXPOSURE
The first, most basic question is how to assess fetal exposure to
sex steroid hormones. Several studies have inferred fetal exposure
to sex steroids from prenatal maternal distress (13, 23), although
direct evidence of an association has not been found, e.g., Ref.
(24). Directly measuring fetal exposure to sex steroids remains a
major challenge. In the past, many studies were able to measure
hormones in amniotic fluid when there was clinical indication;
however, amniocentesis is losing favor as a clinical diagnostic tool
and is unlikely to be a viable measurement strategy moving for-
ward. Less direct measures of fetal exposure may be obtained from
the mother; saliva, serum,and hair have been suggested as potential
candidates. Circulating maternal hormone levels may represent
production by the fetus, placenta, and the mother herself, with
the relative proportions differing by hormone and stage of gesta-
tion (25–27). Circulating maternal testosterone levels could be a
useful index, but it is likely that most fetal androgens are arom-
atized by the placenta before reaching maternal circulation (28).
Finally, if circulating maternal sex steroids are correlated with fetal
exposure, it still remains unclear which maternal medium is most
appropriate for measurement, given that there may be inconsisten-
cies across media (29). In any event, there is good reason to suspect
that peripheral maternal levels of sex steroids may have minimal
influence on fetal exposure. One potentially valuable strategy to
index fetal exposure is to examine placental gene expression (see
below).
Indexing fetal exposure to sex steroids in utero is an essential
but difficult task for research. The availability of non-intrusive
and reliable estimates of fetal exposure has proved difficult and is
a central challenge to overcome in future research.
DISTINGUISHING BETWEEN CORRELATED STEROID HORMONE
EXPOSURES
Distinguishing the impact of sex steroid hormones from other
sources of programing is another major challenge for research.
For example, cortisol and testosterone are positively correlated in
fetal blood (30) and in amniotic fluid (31). Given that, it may be
difficult to separate programing effects attributable to sex steroids
from those attributable to glucocorticoids. One approach in past
research is to examine natural experiments in which a medical con-
dition, such as congenital adrenal hyperplasia (CAH), alters the
fetal hormonal milieu in a well-characterized manner. Findings
from studies of girls with CAH, for example, have helped to estab-
lish that prenatal exposure to sex steroids may program postnatal
outcomes ranging from play behavior, to motor development, to
personality (32–34). Interestingly, females with non-classical CAH
have “female-typical” genitalia at birth (with evidence of impaired
fertility later in life) (35), however, this does not rule out the pos-
sibility of subtly masculinized AGD, which would not be evident
to a casual observer.
On the other hand, it is unclear if the findings can be gener-
alized to non-clinical populations with fetal hormonal exposures
within the normal range of variation. Other means of differen-
tiating between glucocorticoid and sex steroid-based programing
within healthy populations are needed. It is an interesting possi-
bility that the developmental programing studies associated with
maternal prenatal distress may have over-attributed effects to stress
hormones because they have (largely) ignored sex steroids.
ROLE OF PLACENTAL STRUCTURE AND FUNCTION
A novel and potentially promising approach to indexing fetal
steroid hormone exposure is to examine placental gene expres-
sion and epigenetic changes. As the main maternal–fetal interface,
the placenta is of inarguable importance for understanding devel-
opmental programing. To date, research has been influenced by
a glucocorticoid-mediated model. For instance, there has been
great interest in the effects of stress on placental production of 11-
β-hydroxysteroid dehydrogenase 2 (11BHSD2), an enzyme which
shields the fetus from maternal cortisol by converting it to inactive
cortisone (36). However, the placenta’s endocrine production and
regulation clearly extend far beyond 11BHSD2; prenatal distress
may affect other placental steroid hormone pathways, impacting
sex steroidogenesis and activity. At the same time, remarkably
few studies on developmental programing have looked forward
from placental structure and function to clinical phenotypes in
the offspring; exploratory work on this subject is needed.
There are obviously substantial hurdles to assessing placental
gene expression; it is a methodology that poses significant col-
lection, cost, and laboratory demands. In healthy pregnancies,
moreover, we are limited to looking at placental morphology and
physiology at birth rather than at critical periods earlier in ges-
tation. Nevertheless, examining placental variation, particularly
in steroidogenesis pathway activity, in relation to prenatal expo-
sures and postnatal outcomes requires attention given the (other)
inherent challenges of estimating fetal exposure to sex steroids in
a non-intrusive, reliable way.
IDENTIFYING RELEVANT POSTNATAL PHENOTYPES
A final challenge to be considered is the selection of relevant
postnatal phenotypes. Traits with notable sex differences may
be the most fruitful starting points. Autism spectrum disorders
and associated traits, for instance, differ quite notably in preva-
lence and presentation between the sexes (37). Play behavior is
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another strong candidate given the extensive evidence that from
early childhood onward, males and females show clear preferences
for sex-typical toys (38). Both autism and sexually dimorphic
play behaviors have been associated with exposure to prenatal
stress (17, 23), although further work is clearly needed. Other
phenotypes that do not show consistent sex differences, such as
temperament, may be less relevant to consider in this context.
Levels of circulating sex hormones are extremely low from
shortly after birth until puberty. Nevertheless, even in infancy
there appears to be sex differences in neurodevelopmental traits
(39), suggesting that there may be prenatal, organizational effects
of exposure of sex steroids. Other sex differences in development
(in brain development, for instance), emerge later in childhood,
but prior to the peripubertal increase in sex hormones and may
plausibly be the product of in utero sex steroid programing. Stud-
ies showing sex differences in infancy are interesting because there
are minimally detectable levels of sex hormones in circulation;
that means that these infant sex differences may be induced by
prenatal sex steroid exposure. There are other well-known dif-
ferences between the sexes that are evident early in development,
including physical growth and brain development, e.g., Ref. (40). A
challenge for future research is to examine if these – and perhaps
other – early-emerging sex differences in biology and behavior
can be attributable in part to prenatal programing of sex steroid
exposure.
CONCLUSION
Research on human health and development is just beginning to
translate the animal work on developmental programing effects of
sex steroids. Further studies are needed to substantiate this emerg-
ing line of investigation and to provide a broader biological context
in which to interpret the sizable research based on developmental
programing associated with prenatal stress and HPA axis mech-
anisms, a literature which has begun to influence practice and
policy, e.g., Ref. (41). Progress in the area of research will require
the consideration and surmounting of several methodological
challenges, which we have highlighted.
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